title: [Prognostic significance of some markers in cutaneous melanoma treated with different therapeutic modalities].
abstract: The paper discusses the prognostic significance of Ki-67, bcl-2 and HMB-45 markers in skin melanoma in the course of different modalities of chemotherapy involving autoblood. Recurrence-free and 3-year survival among patients receiving autoblood preparations was significantly higher than in controls (p < or = 0.05).
authors.forename: E M
authors.initials: EM
authors.lastname: Nepomniashchaia
authors.forename: M A
authors.initials: MA
authors.lastname: Gusareva
authors.forename: S V
authors.initials: SV
authors.lastname: Petrov
mesh_terms: D000328:Adult; D000368:Aged; D000951:Antigens, Neoplasm / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis*; D017024:Chemotherapy, Adjuvant / Q000379:methods; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000032:analysis; D008297:Male; D008545:Melanoma / Q000737:chemistry* / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D058950:Melanoma-Specific Antigens; D008875:Middle Aged; D020360:Neoadjuvant Therapy / Q000379:methods; D009361:Neoplasm Invasiveness; D009363:Neoplasm Proteins / Q000032:analysis; D011237:Predictive Value of Tests; D011379:Prognosis; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000032:analysis; D012878:Skin Neoplasms / Q000737:chemistry* / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D019394:Ki-67 Antigen; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins; D019253:Proto-Oncogene Proteins c-bcl-2